Lowe’s Companies (NYSE: LOW) is scheduled to report its earnings results for the second quarter on Wednesday before the market opens. The results will be hurt by the convergence of cost pressure, a significant transition in merchandising organization, and ineffective legacy pricing tools and processes.
The company’s products revenue will be benefited by the in-store and online merchandise purchases, while services revenue will be driven by the professional installation services made through subcontractors. The majority of revenue for goods and services will be recognized in the quarter following revenue deferral.
The company’s future success depends on its ability to adapt the business concept to respond to customers’ changing shopping habits and demands as the home improvement retail environment is rapidly evolving. The results will be impacted by the failure to identify changing trends, business concept adaptation, implement change, growth and productivity initiatives.
The company has relied on the public debt markets to fund portions of its capital investments and the commercial paper market and bank credit facilities to fund its working capital needs. The company’s credit strength depends on liquidity and access to capital that relies on efficient, rational and open capital markets.
Analysts expect the company’s earnings to fall by 3.40% to $2.00 per share while revenue will rise by 0.30% to $20.96 billion for the second quarter. In comparison, during the previous year quarter, Lowe’s posted a profit of $2.07 per share on revenue of $20.89 billion. The company has surprised investors by beating analysts’ expectations thrice in the past four quarters.
Read: Analog Devices Q3 earnings preview
For the first quarter, Lowe’s reported a 2% increase in earnings helped by a tax benefit arising from its sale of the assets of Mexico retail operations. Total sales rose by 2.2% and comparable sales grew by 3.5%. Comparable sales for the US home improvement business increased by 4.2%.
For fiscal 2019, the company expects total sales growth of about 2% and comparable sales to increase by about 3%. The earnings are predicted to be in the range of $5.54 to $5.74 per share and adjusted earnings are anticipated to be in the range of $5.45 to $5.65 per share.
Get access to timely and accurate verbatim transcripts that are published within hours of the event.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on
Comments
Comments are closed.